InterMed Medical Appointed Exclusive Distributor in Australia and New Zealand for Inotec

[Cambridge, UK – 20 July 2021] – Inotec AMD Ltd. announces InterMed Medical will be its exclusive distributor for Australia and New Zealand. On the back of increased demand worldwide, this partnership will expand Inotec’s global reach through InterMed’s extensive wound care market knowledge and enhance InterMed’s portfolio offering.

“We’re excited about making NATROX^® available to patients in Australia and New Zealand,” said Ben Darling, Country Manager for InterMed Australia. “We have a unique opportunity to transform people’s lives with something as simple as oxygen.”

Chronic wounds pose a significant problem both on patient quality of life and costs to healthcare systems worldwide.[i] With total healthcare spending of $22 billion (USD)[ii] in New Zealand and upwards of $137 billion² in Australia, and expected to rise as elderly and diabetic populations increase², remote care can prove to be a big benefit considering the low population densities of Australia and New Zealand.[iii]

InterMed will distribute Inotec’s innovative, portable medical device, NATROX® Oxygen Wound Therapy. Positioned as a solution to help reduce the growing burden of chronic wounds, the device generates and delivers oxygen directly to a wound to stimulate healing, even allowing patients to be treated at home.

Craig Kennedy, CEO of Inotec, says collaborating with InterMed is a natural choice. “Their team understand first-hand the increasing pressure healthcare providers face and how to help.” The distribution agreement between Inotec and InterMed began in May, and NATROX® availability in Australia and New Zealand begins soon.

About Inotec AMD, Ltd.

Inotec AMD, Ltd. is a specialist wound care company based in Cambridge, England. Formed specifically to introduce new technologies to healthcare professionals worldwide and promote faster, better healing to patients, the company is positioning NATROX® to be an integral part of global wound care treatment regimes in the coming years. To learn more, visit: natroxwoundcare.com.

About InterMed Medical

InterMed is a well-established distribution company which has been supplying the healthcare market in New Zealand since 1980 and the Australian healthcare market since 2013. We are proud to partner with a broad range of international and local suppliers to access well-respected brands and quality products for these countries. InterMed supplies products in several different categories used across the breadth of the healthcare environment.

# # #

References

[i] Gottrup, F. 2020. Portable, practical and effective: clinical benefits of NATROX® topical oxygen therapy. Journal of Wound Care May 2020, 29(5):53.

[ii] Emergo, 2015. Worldwide spending on healthcare [online] Available at: https://bit.ly/emergoWW [Accessed 23 June 2021].

[iii] Our World in Data, 2016. Population by country, 1500 to 2000. [online] Available at: https://bit.ly/OWIDpop [Accessed 01 July 2021].